Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Oncology

• Publication date

  2004-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2004.22.90140.5505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• An epidermal growth factor receptor‐targeting immunotoxin based on IgG shows potent antitumor activity against head and neck cancer

  2024cites this paper
• Assessment of Renal Function in Head and Neck Cancer Patients Treated with Cisplatin: Different Biomarkers and Acute Kidney Injury Classifications

  2022cites this paper
• Treatment outcomes of proton beam therapy combined with retrograde intra-arterial infusion chemotherapy for locally advanced oral cancer in the elderly.

  2022cites this paper
• Role of Organ Preservation in Locally Advanced Hypopharyngeal Carcinoma

  2021cites this paper
• Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

  2020cites this paper
• Supportive care is mandatory for successful radiotherapy and chemoradiotherapy in patients with head and neck tumors

  2018cites this paper
• Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study

  2017cites this paper
• ORGANOPRESERVACIÓN NO QUIRÚRGICA EN CÁNCER DE CABEZA Y CUELLO Nuevas perspectivas de manejo conservador en los pacientes con tumores avanzados de cabeza y cuello

  2016cites this paper
• Oral squamous cell carcinoma: the impact of stage-dependent therapy regimes on postoperative disease recurrence.

  2016cites this paper
• Effects of High-Dose Cisplatin Chemotherapy and Conventional Radiotherapy on Urinary Oxidative and Nitrosative Stress Biomarkers in Patients with Head and Neck Cancer.

  2016cites this paper
• Cancer of the Hypopharynx

  2016cites this paper
• Quality of Life of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving High-Dose Cisplatin Chemotherapy and Radiotherapy

  2015cites this paper
• Impact of the addition of chemotherapy to radiotherapy for oropharyngeal cancer in 2003–2004: Population‐based study from the Province of Ontario, Canada

  2015cites this paper
• Influence of Pathologic Complete Response to Induction Chemotherapy onLong-Term Survival of Patients Advanced Squamous Cell Carcinoma of the OralCavity Tongue

  2014cites this paper
• Influence of pathologic complete response to neoadjuvant chemotherapy on long-term survival of patients with advanced head and neck squamous cell carcinoma.

  2013cites this paper
• The diagnosis and treatment of oral cavity cancer.

  2012cites this paper
• Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.

  2012cites this paper
• Carcinoma glótico: diagnóstico de sospecha en paciente fumador con disfonía persistente

  2012cites this paper
• Efficacy of super-selective neck dissection following chemoradiation for advanced head and neck cancer.

  2012cites this paper
• The role of cetuximab in the management of head and neck cancers

  2012cites this paper
• Rehabilitation of Heavily Treated Head and Neck Cancer Patients

  2011cites this paper
• Head and Neck CancersPractice Guidelines in Oncology

  2011cites this paper
• Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck

  2011cites this paper
• Collaborative Dysphagia Care for Chemoradiation Patients

  2011cites this paper
• Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.

  2010cites this paper
• Radiotherapy for laryngeal squamous cell carcinoma: current standards

  2010cites this paper
• Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.

  2010cites this paper
• Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers

  2010cites this paper
• Radiochemotherapy with cetuximab, cisplatin, and amifostine for locally advanced head and neck cancer: a feasibility study.

  2010cites this paper
• La chimiothérapie néoadjuvante danslescancers pulmonaires non àpetites cellules : état deslieux etperspectives d’avenir

  2010cites this paper
• Hyperfractionated or accelerated radiotherapy for head and neck cancer.

  2010cites this paper
• Current state-of-the-art for concurrent chemoradiation.

  2009cites this paper
• A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck

  2009cites this paper
• Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.

  2009cites this paper
• Pretreatment Prognostic Factors Influencing Distant Metastasis-Free Survival in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Treated With Radiation Therapy With or Without Concurrent Chemotherapy

  2009cites this paper
• Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.

  2009cites this paper
• The Contribution of Chemotherapy

  2009cites this paper
• Treatment Options for Laryngeal and Hypopharyngeal Cancer

  2009cites this paper
• Radiation Therapy for Head and Neck Cancer

  2009cites this paper
• Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.

  2009cites this paper
• Pretreatment Prognostic Factors of Survival in Patients With Locally Advanced Nonmetastatic Squamous Cell Carcinoma of the Head and Neck Treated With Radiation Therapy With or Without Concurrent Chemotherapy

  2009cites this paper
• Current and emerging standards of concomitant chemoradiotherapy.

  2008cites this paper
• Head and neck cancer

  2008cites this paper
• Optimizing approaches to head and neck cancer: strengths and weaknesses in multidisciplinary treatments of locally advanced disease.

  2008cites this paper
• Intra-arterial chemoradiation for T3-4 oral cavity cancer: Treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma

  2008cites this paper
• Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes.

  2008cites this paper
• Controversies surrounding the use of neoadjuvant chemotherapy in locally advanced head and neck cancer

  2008cites this paper
• Swing of the pendulum: Optimizing functional outcomes in larynx cancer

  2008cites this paper
• Combined chemoradiotherapy advances.

  2008cites this paper
• Pretreatment Prognostic Factors of Local Recurrence-Free Survival in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Treated With Radiation Therapy With or Without Concurrent Chemotherapy

  2008cites this paper
• Clinical application of EGFR inhibitors in head and neck squamous cell cancer.

  2008cites this paper
• Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer

  2008cites this paper
• Understanding the results of meta-analyses in the treatment of head and neck squamous cell cancer.

  2008cites this paper
• Axillary and Subcutaneous Breast Metastases from Rhinopharyngeal Carcinoma: A Case Report and Literature Review

  2008cites this paper
• Long‐term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer

  2008cites this paper
• Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma.

  2007cites this paper
• Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?

  2007cites this paper
• Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer.

  2007cites this paper
• The chemoradiation paradigm in head and neck cancer

  2007cites this paper
• Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.

  2007cites this paper
• High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma

  2007cites this paper
• Evidence-based radiation oncology in head and neck squamous cell carcinoma.

  2007cites this paper
• Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway

  2007cites this paper
• Biological agents in head and neck cancer

  2007cites this paper
• Necrotizing fasciitis as a late complication of multimodal treatment for locally advanced head and neck cancer: A case report

  2007cites this paper
• Tumores del área ORL. Tratamiento de quimiorradioterapia

  2007cites this paper
• Standard of care for locally advanced head and neck cancer (LA-HNSCC)

  2007cites this paper
• Combination of radiotherapy with EGFR antagonists for head and neck carcinoma

  2007cites this paper
• Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-κB expression and proteasome activation in head and neck squamous carcinoma cell lines

  2007cites this paper
• Chemoradiotherapy for locally advanced head and neck cancer.

  2007cites this paper
• Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?

  2007cites this paper
• Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

  2007cites this paper
• Superselective neck dissection after chemoradiation: feasibility based on clinical and pathologic comparisons.

  2007cites this paper
• Applications in Head and Neck Cancer

  2006cites this paper
• A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.

  2006cites this paper
• Lippen-, Mundhöhlen- und Oropharynxtumoren

  2006cites this paper
• Altered fractionated radiotherapy in head and neck cancer – Authors' reply

  2006cites this paper
• Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.

  2006cites this paper
• Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

  2006cites this paper
• Laryngeal preservation in head and neck cancer: multidisciplinary approach.

  2006cites this paper
• Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus.

  2006cites this paper
• Adjuvant therapy in patients with resected poor-risk head and neck cancer.

  2006cites this paper
• Altered fractionation: a fractional benefit?

  2006cites this paper
• Cancers du larynx

  2006cites this paper
• Biological agents in head and neck cancer.

  2006cites this paper
• Epidermal growth factor receptor directed therapy in head and neck cancer.

  2006cites this paper
• Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer

  2006cites this paper
• Chemo-radiotherapy in head and neck cancer.

  2006cites this paper
• MOLECULAR TARGETS FOR RADIOSENSITIZATION

  2006cites this paper
• Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.

  2006cites this paper
• Cáncer de laringe

  2006cites this paper
• New trends in radiotherapy for head and neck cancer.

  2005cites this paper
• Medical treatment in head and neck cancer.

  2005cites this paper
• New Approaches to Postoperative Radiotherapy for Cancer of the Head and Neck

  2005cites this paper
• Traitement des carcinomes épidermoïdes localement évolués des voies aéro-digestives supérieures: place de la radio-chimiothérapie

  2005cites this paper
• Induction Chemotherapy in Head and Neck Cancer

  2005cites this paper
• Apport des méta-analyses sur données individuelles au traitement des cancers ORL

  2005cites this paper
• Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.

  2005cites this paper
• Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?

  2005cites this paper
• Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.

  2005cites this paper